Filter
2828
Filtered Results: 2828
Text search:
Laboratory
commodities
Featured
Recommendations
298
New Publications
903
Language
Document type
No document type
1666
Studies & Reports
413
Guidelines
351
Strategic & Response Plan
157
Manuals
132
Training Material
35
Fact sheets
31
Situation Updates
30
Infographics
5
Brochures
4
Resource Platforms
3
Online Courses
1
Countries / Regions
Sierra Leone
107
Liberia
105
Kenya
105
Global
103
India
102
Ethiopia
80
Uganda
80
Nigeria
77
Tanzania
68
Africa
54
South Africa
53
Zambia
52
Malawi
52
Nepal
49
Western and Central Europe
47
Rwanda
43
Congo, Democratic Republic of
40
Bangladesh
39
Ghana
35
Myanmar / Burma
32
Guinea
31
Latin America and the Carribbean
30
South–East Asia Region
27
Syria
26
Zimbabwe
25
Philippines
25
Namibia
25
West and Central Africa
25
Lesotho
24
East and Southern Africa
24
Cambodia
23
Ukraine
22
Eastern Europe
21
Senegal
20
Asia
18
Botswana
16
Mozambique
15
Haiti
13
Pakistan
12
South Sudan
12
Middle East and North Africa
12
Eswatini/ Swaziland
11
Colombia
11
Indonesia
10
Cameroon
9
Benin
8
Madagascar
8
Western Pacific Region
8
Burkina Faso
7
Eastern Europe and Central Asia
7
Somalia
6
Venezuela
6
Albania
6
Moldova
6
USA
5
Afghanistan
5
Thailand
5
Brazil
5
Yemen
5
Russia
5
Georgia
5
Mali
4
Germany
4
Papua New Guinea
4
Central African Republic
4
Burundi
4
Laos
4
Tajikistan
4
Vietnam
4
Iraq
3
Sudan
3
Bolivia
3
Angola
3
Armenia
3
Côte d’Ivoire / Ivory Coast
2
Togo
2
Jordan
2
Lebanon
2
Chad
2
Gambia
2
China
2
Peru
2
North Macedonia
2
Ecuador
2
Sri Lanka
2
Paraguay
2
Bhutan
2
Southern Africa
2
Timor Leste/ East Timor
2
Bulgaria
2
Iran
2
North America
2
Jamaica
2
Mauritius
2
United Kingdom
2
Portugal
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Turkey
1
Argentina
1
Dominican Republic
1
Switzerland
1
Serbia
1
Hungary
1
Greece
1
Libya
1
Chile
1
Poland
1
Palestine
1
Qatar
1
Romania
1
Lithuania
1
Slovakia
1
Gabon
1
Turkmenistan
1
Japan
1
France
1
Maldives
1
Tunisia
1
Spain
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1228
Clinical Guidelines
237
Public Health
154
Key Resources
109
Women & Child Health
84
Capacity Building
48
Pharmacy & Technologies
34
Annual Report MEDBOX
1
Toolboxes
COVID-19
235
HIV
230
TB
228
Rapid Response
152
Ebola
144
AMR
121
NTDs
106
Planetary Health
72
Mental Health
59
Conflict
50
Caregiver
49
Pharmacy
49
Cholera
33
Refugee
31
NCDs
29
Zika
26
Global Health Education
26
Polio
23
Natural Hazards
21
Specific Hazards
19
Disability
18
Health Financing Toolbox
18
Social Ethics
3
Typhoon
1
Le Groupe spécial mondial de lutte contre le choléra (GTFCC) a lancé Mettre fin au choléra :
Une feuille de route mondiale pour 2030 (la Feuille de route mondiale) (1). Cette stratégie vise
à réduire de 90 % le nombre de décès dus au choléra dans le monde et à mettre fin à la
malad...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO guidance. The m...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
SAMS team rose to meet these challenges, delivering world class COVID treatment with four newly established COVID hospitals complete with 100 ICU beds and state of the art equipment like ventilators, monitors, and oxygen generators. By using innovative technologies, SAMS’ physicians were able to s...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re...
Caregiver: Standard precautions
recommended
Issue Brief 28: Cargiver Toolbox Part 2
A collection of important documents from the category "Standard precautions", including hand hygiene, waste management, infection and prevention control (IPC) measures.
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
What are the FP and CAC competencies?
Through the clear articulation of the family planning and comprehensive abortion care (FP and CAC) competencies for the primary health care workforce, the aim is to advance improvements in FP and CAC service delivery by aligning health worker education approach...
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
